olmesartan has been researched along with Atrioventricular Conduction Block in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, ZY; Huang, K; Pan, C; Zhang, H; Zhang, J; Zhong, Y; Zhu, LL | 1 |
1 trial(s) available for olmesartan and Atrioventricular Conduction Block
| Article | Year |
|---|---|
Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients.
Topics: Aged; Angiotensin Receptor Antagonists; Atrial Fibrillation; Atrioventricular Block; Female; Humans; Imidazoles; Male; Middle Aged; Single-Blind Method; Tetrazoles | 2016 |